Christopher Lieu, Professor of Medical Oncology, University of Colorado Anschutz – World News Intel

TECH

FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival

Christopher Lieu, Professor of Medical Oncology, University of Colorado AnschutzAugust 26, 2026

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For…

TECH

Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease

Christopher Lieu, Professor of Medical Oncology, University of Colorado AnschutzJune 2, 2026

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For…